Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Intertek Experts Highlight the Analytical and Regulatory Challenges for Nanomaterials



  Intertek Experts Highlight the Analytical and Regulatory Challenges for
  Nanomaterials

Business Wire

MANCHESTER, England -- March 22, 2013

Intertek, the leading quality solutions provider to industries worldwide, has
highlighted the analytical and regulatory challenges associated with the
inclusion of nanomaterials to formulated products in a recent article.

Recently published in Speciality Chemicals Magazine, Intertek’s experts Dr
Simon Allen and Dr Lorna Kettle discuss the definition of nanomaterials, the
use and characterisation of nanomaterials in pharmaceuticals and cosmetics and
summarise the developing regulatory environment.

The potential for nanotechnology is vast and it is quietly making its way into
many products in daily life. Chemicals majors are among those leading the way,
both through their own work and in partnership with academia and small
specialists. Important challenges for developers of nanotechnology lie ahead
and relate primarily to establishing validated methods and instrumentation for
detection, characterisation and analysis, compiling relevant information on
hazards of nanomaterials and developing methods to assess exposure to
nanomaterials.

The regulatory landscape continues to evolve. In order to show regulatory
compliance and correct implementation of EC definitions, appropriate
instrumentation and methodology are critical. “The accuracy of analytical
approaches is crucial if the data are to be used in notification or labelling
procedures. Method validation is also a key issue” shares Dr Simon Allen,
Laboratory Director, Intertek Chemicals and Pharmaceuticals. “Researchers and
manufacturers must have the tools available to be able to comprehensively
understand their products.”

Intertek has broad experience in the characterisation of nanomaterial
ingredients and in formulated products such as cosmetics, pharmaceuticals,
paints, coatings, electronic materials and more. Intertek also add value
through expert toxicology knowledge for nanomaterial risk assessments.

“Intertek’s broad materials expertise, the wide scope of analytical technology
coupled with the knowledge of how to apply this to nano-sized systems,
positions Intertek well to support our client’s innovation in nanomaterials
across the globe.” said Dr Phil Norman, Senior Vice President, Intertek
Chemicals and Pharmaceuticals. “Intertek was pleased to have been invited to
author this article for Speciality Chemicals magazine.”

To read the full article, please visit:
http://edition.pagesuite-professional.co.uk/Launch.aspx?PBID=67f08a11-651b-4137-b71f-7b095df83d87

About Intertek

Intertek is the leading quality solutions provider to industries worldwide.
From auditing and inspection, to testing, training, advisory, quality
assurance and certification, Intertek adds value to customers’ products,
processes and assets. With a network of more than 1,000 laboratories and
offices and over 35,000 people in more than 100 countries, Intertek supports
companies’ success in a global marketplace. Intertek helps its customers to
meet end users’ expectations for safety, sustainability, performance,
integrity and desirability in virtually any market worldwide. Visit
www.intertek.com.

Contact:

Intertek Chemicals & Pharmaceuticals
Dr Simon Allen, Laboratory Director, Wilton
Telephone: +44 (0) 1642 435755
simon.allen@intertek.com
or
Intertek Chemicals & Pharmaceuticals
Dr Lorna Kettle, European Marketing and Communications Manager
Telephone: +44 (0) 161721 1476
lorna.kettle@intertek.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement